Molecular pharmacology of alpha adrenergic receptors: utilization of [3H]dihydroergocryptine binding in the study of pharmacological receptor alterations.
D000818:Animals; D001667:Binding, Competitive; D002413:Cations, Divalent; D004088:Dihydroergotoxine / Q000378:metabolism*; D005260:Female; D066298:In Vitro Techniques; D007700:Kinetics; D008024:Ligands; D008566:Membranes / Q000187:drug effects / Q000378:metabolism; D009215:Myometrium / Q000378:metabolism / Q000648:ultrastructure; D010643:Phenoxybenzamine / Q000494:pharmacology; D010646:Phentolamine / Q000494:pharmacology; D011817:Rabbits; D011941:Receptors, Adrenergic / Q000187:drug effects*; D011942:Receptors, Adrenergic, alpha / Q000187:drug effects* / Q000378:metabolism; D013439:Sulfhydryl Reagents / Q000494:pharmacology; D013997:Time Factors
D002413:Cations, Divalent; D008024:Ligands; D011941:Receptors, Adrenergic; D011942:Receptors, Adrenergic, alpha; D013439:Sulfhydryl Reagents; D010643:Phenoxybenzamine; D004088:Dihydroergotoxine; D010646:Phentolamine